PHRMAG and the Authority of Social Contribution – Ma’an Partner to Enhance Oncology and Rare Disease Care in Abu Dhabi...

PHRMAG and the Authority of Social Contribution – Ma’an Partner to Enhance Oncology and Rare Disease Care in Abu Dhabi

The Pharmaceutical Research and Manufacturers Association in Gulf (PHRMAG), the region’s leading innovative biopharmaceutical research companies, and the Authority of Social Contribution – Ma’an, the Abu Dhabi Government’s official channel to receive social contributions, has announced a strategic collaboration aimed at enabling access  for oncology and rare disease patients most in need to innovative solutions […]

Editor  |   |  3 mins read
Read Full Story →
Wegovy® pill approved in the US as first oral GLP-1 for weight management - wegovy pill

Wegovy® pill approved in the US as first oral GLP-1 for weight management

Wegovy® pill showed a mean weight loss of 16.6% in the OASIS 4 trial Wegovy® pill is indicated to reduce excess body weight and maintain weight reduction long-term and to reduce the risk of major adverse cardiovascular events* Novo Nordisk expects to launch Wegovy® pill in the US in early January 2026 Dubai, 24 December 2025- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Wegovy® pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events*. The Wegovy®

Editor  |   |  2 mins read
Read Full Story →